This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Zacks Investment Ideas feature highlights: Anthem, UnitedHealth Group and Molina Healthcare
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Anthem, UnitedHealth Group and Molina Healthcare
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the prospering health insurance industry. On comparative evaluation, we try to discover which stock is more profitable, based on the fundamentals.
Neutralize Higher Health Insurance Premiums In 2022
by Bryan Hayes
Buy These Health Providers to Counteract Bigger Health Insurance Premiums
Why Buying Molina Healthcare (MOH) is a Prudent Move Now?
by Zacks Equity Research
Molina Healthcare's (MOH) total revenues for 2021 are anticipated to be no less than $27.5 billion.
Should SPDR S&P MidCap 400 ETF (MDY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MDY
HCA Healthcare (HCA) Up 53.3% in a Year: More Room to Run?
by Zacks Equity Research
HCA Healthcare's (HCA) strategic measures and strong patient volumes will likely lead to better revenues, thus perking up its share price.
Tenet Healthcare (THC) Soars 95.8% YTD: More Room to Run?
by Zacks Equity Research
Banking on a solid guidance, enhanced portfolio and strategic measures, Tenet Healthcare (THC) holds enough potential to reap benefits for investors.
Molina (MOH) Upgraded to Buy: Here's Why
by Zacks Equity Research
Molina (MOH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
4 Health Insurers Poised to Maintain Winning Streak in 2022
by Kaibalya Pravo Dey
Buoyed by government support and technological improvements, stocks in the health insurance industry are likely to witness increased product demand. UNH, ANTM, CNC & MOH are well positioned to make the most of the market improvement.
Here's Why Investors Should Hold Onto Ensign Group (ENSG)
by Zacks Equity Research
Riding high on a solid portfolio and a rising top line, Ensign Group (ENSG) holds enough potential to reap benefits for investors.
UnitedHealth's (UNH) Arms Receive Rating Actions From AM Best
by Zacks Equity Research
UnitedHealth's (UNH) subsidiaries get rating upgrades from AM Best. Moreover, outlook of the ratings is revised to stable.
Should SPDR Portfolio S&P 400 Mid Cap ETF (SPMD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPMD
UnitedHealth (UNH) Ups Guidance: Here's What You Should Know
by Zacks Equity Research
UnitedHealth's (UNH) 2022 bottom line estimates are below the Zacks Consensus Estimate, may be due to an uptick in insurance claims triggered by the coronavirus pandemic.
UnitedHealth (UNH) Extends Plan Coverage in Massachusetts
by Zacks Equity Research
UnitedHealth Group's unit (UNH) provides an integrated health benefit plan in a bid to offer better health outcomes for eligible members in Massachusetts, who qualify for both Medicare and MassHealth.
Tenet Healthcare (THC) Offers Senior Secured Notes of $1.45B
by Zacks Equity Research
Tenet Healthcare (THC) issues senior notes to procure funds. The move further highlights THC's sound financial position.
Molina Healthcare (MOH) Offers $750M, 3.875% Senior Notes
by Zacks Equity Research
Molina Healthcare (MOH) shows discretion in issuing senior notes amid a low-interest rate environment, which in turn, will procure funds.
Should Vanguard S&P MidCap 400 ETF (IVOO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOO
Anthem (ANTM) to Acquire Integra to Enhance Medicaid Business
by Zacks Equity Research
Anthem (ANTM) to buy Integra Managed Care from a wholly-owned indirect unit of Personal Touch Holding Corporation to bolster its Medicaid Business profile.
Should iShares Core S&P MidCap ETF (IJH) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJH
MEDNAX's (MD) Q3 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
MEDNAX's (MD) third-quarter results reflect growing revenues driven by rising patient volumes, partly offset by higher general and administrative expenses.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Molina Healthcare's (MOH) Q3 Earnings Beat Mark, Fall Y/Y
by Zacks Equity Research
Molina Healthcare (MOH) Q3 earnings gain from better revenues, partly offset by steep expenses.
Molina (MOH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 2.54% and 4.43%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?